Accelerated Approval Submission On The HORIZON For Oncopeptides’ Melflufen

Multiple myeloma (showing flame-shaped plasma cell) - Image
Recent regulatory discussions on Oncopeptides multiple myeloma candidate were “even better than we anticipated.” • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards